… of COVID-19 disease. This systematic review aimed to investigate the efficacy of supplemental
curcumin treatment on clinical outcomes and inflammation-related biomarker profiles in …

… curcumin confers clinical benefits in patients with COVID-19. … are needed to establish the
clinical efficacy of the curcumin. … to moderate hospitalized coronavirus disease-19 patients: An …

… benefits of curcumin in patients with COVID‐19, and we aimed to summarize their overall
efficacy in terms of mortality reduction in a systematic review … risk of mortality while hospitalized. …

… (ii) Thromboembolic events have been frequently reported in hospitalized patients with
COVID-19. Increased D-dimer is a well-known marker indicating thrombotic propensity and a …

… efficacy of curcumin for various clinical outcomes in the treatment of … curcumin increases
the rate of recovery in COVID-19 patients. The lack of benefit for the incidence of hospitalization …

… Additionally, the efficiency of curcumin therapy in clinical studies was recently the subject
of a systematic review, which indicated that it decreased the duration of typical …

… curcumin efficacy and safety in COVID-19 infection. As mentioned above, in this open-label
nonrandomized study, … to supplemental O 2 , and hospitalization was meaningfully shorter in …

… , this systematic review evaluated the effects of curcumin among patients with COVID 19. …
symptoms, duration of hospitalization, and death in COVID-19 patients with varying degrees …

… effective strategies to treat infected patients is necessary to decrease the mortality rate. This
study aimed to determine the effects of … curcumin as a complementary therapy for COVID-19 …

… Patients This study included hospitalized COVID-19 patients aged 18 to 80 with a positive
… In the present study, we investigated the therapeutic role of curcumin nanomicelles as a …